U.S. FDA expands use of CDC coronavirus diagnostic test
Tuesday, 4 February 2020 The U.S. Food and Drug Administration on Tuesday extended the use of a coronavirus detection tool to Centers for Disease Control and Prevention (CDC)-qualified laboratories across the country.
The US Food and Drug Administration on Tuesday inserted itself into the spreading coronavirus pandemic. The FDA extended the use of a coronavirus detection tool to Centers for Disease Control and Prevention-qualified laboratories across the country. According to Reuters, the authorization was until...
[NFA] The U.S. Centers for Disease Control and Prevention director on Thursday said his agency will not revise its guidelines for reopening schools despite calls from U.S. President Donald Trump, instead his agency will provide 'additional reference documents' to aid communities. This report produced by Yahaira Jacquez.
Top Trump administration health and education officials on Wednesday pushed for schools to 'fully open' in the fall with CDC Director Robert Redfield saying it would be 'very disappointing' to him if schools used the CDC guidelines as a rationale not to reopen.
Stephen Hahn, the Food and Drug Administration commissioner, said on Sunday it was "too early to tell" if it would be safe for people to attend August's Republican National Convention in Jacksonville, Florida. This report produced by Chris Dignam.
The commissioner of the US Food and Drug Administration on Sunday didn't defend a claim recently made by President Donald Trump. But according to CNN, he didn't support it, either. Dr. Stephen Hahn is a member of the White House coronavirus task force. At a White House Independence Day event on Saturday, Trump made an unfounded claim that 99% of coronavirus cases are 'totally harmless.' In a CNN interview with Dana Bash on Sunday, Dr.
Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies. The FDA officially announced the medicine could be used in treating COVID-19 patients. Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals. Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients. It could shorten satsy by several days, reports Gizmodo.
Former Food and Drug Administration Commissioner Scott Gottlieb on Sunday warned that some U.S. states, including Texas, Florida and Arizona, could start to see an 'exponential' rise in COVID-19 cases this coming week. This report produced by Yahaira Jacquez.